+

WO2001036675A3 - Polymorphismes cd36 - Google Patents

Polymorphismes cd36 Download PDF

Info

Publication number
WO2001036675A3
WO2001036675A3 PCT/GB2000/004384 GB0004384W WO0136675A3 WO 2001036675 A3 WO2001036675 A3 WO 2001036675A3 GB 0004384 W GB0004384 W GB 0004384W WO 0136675 A3 WO0136675 A3 WO 0136675A3
Authority
WO
WIPO (PCT)
Prior art keywords
polymorphisms
abnormalities
genetic
hypertension
susceptibility
Prior art date
Application number
PCT/GB2000/004384
Other languages
English (en)
Other versions
WO2001036675A2 (fr
Inventor
David John Roberts
Arnab Pain
Original Assignee
Isis Innovation
David John Roberts
Arnab Pain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isis Innovation, David John Roberts, Arnab Pain filed Critical Isis Innovation
Priority to AU14049/01A priority Critical patent/AU1404901A/en
Publication of WO2001036675A2 publication Critical patent/WO2001036675A2/fr
Publication of WO2001036675A3 publication Critical patent/WO2001036675A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne une série de nouveaux polymorphismes à nucléotide simple dans le gène humain CD36 offrant une base génétique pour un phénotype CD36 négatif. L'invention concerne également des méthodes de criblage génétique pour déterminer une sensibilité à l'hypertension, des anomalies du métabolisme des acides gras et des anomalies du métabolisme du glucose sur la base de l'utilisation des polymorphismes.
PCT/GB2000/004384 1999-11-19 2000-11-17 Polymorphismes cd36 WO2001036675A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU14049/01A AU1404901A (en) 1999-11-19 2000-11-17 Cd36 polymorphisms

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9927502.6A GB9927502D0 (en) 1999-11-19 1999-11-19 CD36 Polymorphisms
GB9927502.6 1999-11-19

Publications (2)

Publication Number Publication Date
WO2001036675A2 WO2001036675A2 (fr) 2001-05-25
WO2001036675A3 true WO2001036675A3 (fr) 2002-05-02

Family

ID=10864869

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2000/004384 WO2001036675A2 (fr) 1999-11-19 2000-11-17 Polymorphismes cd36

Country Status (3)

Country Link
AU (1) AU1404901A (fr)
GB (1) GB9927502D0 (fr)
WO (1) WO2001036675A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108660198B (zh) * 2018-05-15 2022-02-22 广州血液中心 一种血小板膜蛋白cd36抗原基因分型的pcr-sbt方法及试剂

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1754058B1 (fr) * 2004-05-26 2016-04-13 Region Nordjylland Procédé pour déterminer la quantité de CD36 circulant
ES2571929T3 (es) 2004-05-26 2016-05-27 Region Nordjylland Procedimiento para determinar la cantidad de CD36 circulante

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993006848A1 (fr) * 1991-10-03 1993-04-15 The Center For Blood Research IMMUNOADHESINES DE CD36 ET LEUR UTILISATION POUR TUER DE MANIERE SELECTIVE LES ERYTHROCYTES INFECTES PAR $i(PLASMODIUM FALCIPARUM)
US5506126A (en) * 1988-02-25 1996-04-09 The General Hospital Corporation Rapid immunoselection cloning method
WO2000019883A2 (fr) * 1998-10-07 2000-04-13 Medical Research Council Compositions et methodes permettant de diagnostiquer et de traiter des maladies

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506126A (en) * 1988-02-25 1996-04-09 The General Hospital Corporation Rapid immunoselection cloning method
WO1993006848A1 (fr) * 1991-10-03 1993-04-15 The Center For Blood Research IMMUNOADHESINES DE CD36 ET LEUR UTILISATION POUR TUER DE MANIERE SELECTIVE LES ERYTHROCYTES INFECTES PAR $i(PLASMODIUM FALCIPARUM)
WO2000019883A2 (fr) * 1998-10-07 2000-04-13 Medical Research Council Compositions et methodes permettant de diagnostiquer et de traiter des maladies

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
AITMAN ET AL.: "Identification of Cd36 (fat) as an insulin-resistance gene causing defective acid and glucose metabolism in hypertensive rats", NATURE GENETICS, vol. 21, no. 1, January 1999 (1999-01-01), pages 61 - 62, XP001002349 *
ROCK ET AL.: "Anti-CD36 antibodies in patients with lupus anticoagulant and thrombotic complications", BRITISH JOURNAL OF HAEMATOLOGY, vol. 88, no. 4, December 1994 (1994-12-01), pages 878 - 880, XP001002375 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108660198B (zh) * 2018-05-15 2022-02-22 广州血液中心 一种血小板膜蛋白cd36抗原基因分型的pcr-sbt方法及试剂

Also Published As

Publication number Publication date
GB9927502D0 (en) 2000-01-19
WO2001036675A2 (fr) 2001-05-25
AU1404901A (en) 2001-05-30

Similar Documents

Publication Publication Date Title
MXPA02004880A (es) Genes relacionados con el rendimiento.
AU2001230881A1 (en) Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human heart
WO2001090419A3 (fr) Methodes d'analyse genetique d'adn servant a detecter des variances de sequence
WO2003038123A3 (fr) Procede de traitement du diabete et conditions apparentees basees sur des polymorphismes dans le gene tcf1
WO2005040377A3 (fr) Transfert et expression genique a efficacite elevee dans des cellules de mammiferes au moyen d'une procedure de transfection multiple de sequences mar
EP0404210A3 (fr) Procédé et sonde pour détecter des cellules associées aux maladies orales humaines ou à la gencive saine
WO2001036675A3 (fr) Polymorphismes cd36
WO2001023410A3 (fr) Isogenes cibles a usage medicamenteux: polymorphismes dans le gene d'interleukine
AU2153401A (en) Gene expression in biological conditions
EP1222295A4 (fr) Procede permettant d'augmenter le rendement d'une culture ou la biomasse par utilisation du gene de la protoporphyrinogene oxydase
WO1998032847A3 (fr) Caracterisation du transcriptome de levure
WO1989002440A3 (fr) Sondes d'hybridation a adn specifiques a l'y et utilisations prevues a cet effet
AU6091199A (en) Method for determining susceptibility to heart disease by screening polymorphisms in the vitamin d receptor gene
WO2003018745A3 (fr) Procede de depistage des reactions d'hypersensibilite a des medicaments
WO2005024045A3 (fr) Amorces utiles dans la detection de beta-lactamases
WO2002010203A3 (fr) Genes daz
CA2385872A1 (fr) Transfert de genes dans des lymphocytes humains au moyen de vecteurs retroviraux a ciblage cellulaire scfc
Gurakan et al. Analysis of three mutations in Turkish children with Gaucher disease
WO2004065938A3 (fr) Gene humain de l'osteoporose
WO2001058914A3 (fr) Haplotypes du gene de l'interleukine 15
WO1999006598A3 (fr) Determination d'alleles communs fonctionnels dans une population et applications de ceux-ci
WO2004022719A3 (fr) Genes de predisposition au diabete de type 2
AU5052899A (en) Genetic polymorphisms in the human neurokinin 1 receptor gene and their uses in diagnosis and treatment of diseases
Ogasawara et al. Restriction fragment length polymorphisms of HPRT and APRT genes in Japanese population
WO2005049818A3 (fr) Gene

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载